Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kim Chan Chung
Xbp1s-Negative Tumor B Cells and Pre-Plasmablasts Mediate Therapeutic Proteasome Inhibitor Resistance in Multiple Myeloma
Cancer Cell
Cancer Research
Oncology
Cell Biology
Related publications
Proteasome Inhibitor-Induced Modulation Reveals the Spliceosome as a Specific Therapeutic Vulnerability in Multiple Myeloma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy
Sensors
Instrumentation
Information Systems
Electronic Engineering
Biochemistry
Analytical Chemistry
Molecular Physics,
Electrical
Atomic
Medicine
Optics
The Nuclear Factor (Erythroid-Derived 2)-Like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Sensitizing Human Multiple Myeloma Cells to the Proteasome Inhibitor Bortezomib by Novel Curcumin Analogs
International Journal of Molecular Medicine
Medicine
Genetics
MAFb Protein Confers Intrinsic Resistance to Proteasome Inhibitors in Multiple Myeloma
BMC Cancer
Cancer Research
Oncology
Genetics
Proteasome and Heat Shock Protein 70 (HSP70) Inhibitors as Therapeutic Alternative in Multiple Myeloma
Oncotarget
Oncology
Thiasyrbactins Induce Cell Death via Proteasome Inhibition in Multiple Myeloma Cells
Anticancer Research
Medicine
Cancer Research
Oncology
Nelfinavir Augments Proteasome Inhibition by Bortezomib in Myeloma Cells and Overcomes Bortezomib and Carfilzomib Resistance
Blood Cancer Journal
Oncology
Hematology
Resistance to Proteasome Inhibitors and Other Targeted Therapies in Myeloma
British Journal of Haematology
Hematology